Keyphrases
Cardiac Hypertrophy
100%
NF-B
100%
Isoproterenol
100%
P65 Subunit
100%
Jumonji Domain
100%
Histone
27%
Pathological Cardiac Hypertrophy
27%
Overexpression
18%
Heart Failure
18%
Neonatal Rat Cardiomyocytes
18%
Gene Expression
9%
Therapeutic Intervention
9%
Heart Failure with Preserved Ejection Fraction (HFpEF)
9%
Echocardiography
9%
Hypertrophy
9%
Patients with Heart Failure
9%
Cardiomyocytes
9%
Cardiac Function
9%
Nuclear Translocation
9%
Hypertrophic Response
9%
Cardiac Tissue
9%
Histone Modification
9%
Single Guide RNA (sgRNA)
9%
Subcutaneous Injection
9%
Cardiac Fibrosis
9%
Euthanasia
9%
Hypertrophic Genes
9%
Arginine Demethylase
9%
Biochemistry, Genetics and Molecular Biology
Cardiac Muscle Cell
100%
Histone
100%
Isoprenaline
100%
Gene Expression
33%
Demethylase
33%
Heart Function
33%
Heart Ejection Fraction
33%
Histone Modification
33%
Surface Area
33%
Guide RNA
33%
Arginine
33%
Medicine and Dentistry
Ventricular Hypertrophy
100%
Isoproterenol-Induced Cardiac Hypertrophy
100%
Histone
50%
Cardiac Muscle Cell
50%
Congestive Heart Failure
33%
In Vitro
16%
Echocardiography
16%
Gene Expression
16%
Cardiac Fibrosis
16%
Heart Function
16%
Heart Failure with Reduced Ejection Fraction
16%
Isoprenaline
16%
Arginine
16%
Subcutaneous Injection
16%
Guide RNA
16%
Histone Modification
16%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Ventricle Hypertrophy
100%
Isoproterenol-Induced Cardiac Hypertrophy
100%
Histone
66%
Congestive Heart Failure
33%
Arginine
16%
Heart Failure with Reduced Ejection Fraction
16%
Isoprenaline
16%
Heart Muscle Fibrosis
16%
Subcutaneous Injection
16%
Guide RNA
16%